Literature DB >> 4060597

Descriptive analysis of Ebola virus proteins.

L H Elliott, M P Kiley, J B McCormick.   

Abstract

The virion proteins of two strains of Ebola virus were compared by SDS-polyacrylamide gel electrophoresis (PAGE) and radioimmunoprecipitation (RIP). Seven virion proteins were described; an L (180K), GP (125K), NP (104K), VP40 (40K), VP35 (35K), VP30 (30K), and VP24 (24K). The RNP complex of the virus contained the L, the NP, and VP30, with VP35 in loose association with them. The GP was the major spike protein, with VP40 and VP24 making up the remaining protein content of the multilayered envelope.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4060597     DOI: 10.1016/0042-6822(85)90236-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  76 in total

1.  VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment.

Authors:  Larissa Kolesnikova; Harald Bugany; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding.

Authors:  Ziying Han; Hani Boshra; J Oriol Sunyer; Susan H Zwiers; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Glycosylation and oligomerization of the spike protein of Marburg virus.

Authors:  H Feldmann; C Will; M Schikore; W Slenczka; H D Klenk
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

6.  Functional mapping of the nucleoprotein of Ebola virus.

Authors:  Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.

Authors:  A Groseth; J E Charton; M Sauerborn; F Feldmann; S M Jones; T Hoenen; H Feldmann
Journal:  Virus Res       Date:  2008-12-16       Impact factor: 3.303

8.  Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

Authors:  S Becker; H Feldmann; C Will; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

9.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Role of Ebola virus VP30 in transcription reinitiation.

Authors:  Miguel J Martínez; Nadine Biedenkopf; Valentina Volchkova; Bettina Hartlieb; Nathalie Alazard-Dany; Olivier Reynard; Stephan Becker; Viktor Volchkov
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.